TRCT
GEHC icon

Tower Research Capital (TRC)’s GE HealthCare GEHC Stock Holding History

Tower Research Capital (TRC)’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.81M Buy
39,424
+9,445
+32% +$745K 0.07% 269
2025
Q4 		$2.46M Buy
29,979
+19,892
+197% +$1.55M 0.06% 284
2025
Q3 		$758K Sell
10,087
-5,711
-36% -$426K 0.02% 626
2025
Q2 		$1.17M Buy
15,798
+6,207
+65% +$432K 0.03% 485
2025
Q1 		$774K Sell
9,591
-28,545
-75% -$2.45M 0.02% 611
2024
Q4 		$2.98M Buy
38,136
+19,467
+104% +$1.65M 0.06% 258
2024
Q3 		$1.75M Sell
18,669
-72,266
-79% -$6.07M 0.05% 323
2024
Q2 		$7.09M Buy
90,935
+61,042
+204% +$4.98M 0.12% 140
2024
Q1 		$2.72M Sell
29,893
-36,867
-55% -$3.07M 0.07% 215
2023
Q4 		$5.16M Buy
66,760
+41,269
+162% +$2.89M 0.06% 250
2023
Q3 		$1.73M Buy
25,491
+11,331
+80% +$824K 0.05% 352
2023
Q2 		$1.15M Buy
14,160
+7,505
+113% +$599K 0.04% 428
2023
Q1 		$546K Buy
+6,655
New +$475K 0.02% 774

Other funds holding GEHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Tower Research Capital (TRC)'s GEHC Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its GE HealthCare (GEHC) stake by 32% in Q1 2026, buying an estimated $745K and bringing the position to 39,424 shares worth $2.81M. The position accounts for 0.07% of the portfolio, ranked #269.

Tower Research Capital (TRC) first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $7.09M in Q2 2024. 1,263 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Tower Research Capital (TRC) held 39,424 shares of GE HealthCare worth $2.81M as of Q1 2026.
  • Tower Research Capital (TRC) bought 9,445 GE HealthCare shares in Q1 2026, an estimated $745K.
  • GE HealthCare made up 0.07% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #269 holding.
  • Tower Research Capital (TRC) first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Tower Research Capital (TRC)'s GE HealthCare position peaked at $7.09M in Q2 2024.
  • 1,263 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.